MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09273948.2022.2098147

Медицинская библиотека · Ocular immunology and inflammation · 2022

Ocular Inflammatory Complications of Treatment for Metastatic Melanoma.

Philip Andrew M, Anesi Stephen D, Foster C Stephen, Chang Peter

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To characterize various ocular inflammatory complications arising from metastatic cutaneous melanoma therapies and their management.

METHODS

Retrospective case series of patients who were referred to a tertiary uveitis practice for ophthalmic exam All patients received targeted metastatic cutaneous melanoma treatment, including BRAF/MEK inhibitors and various immunotherapies.

RESULTS

109 patients were identified, with 43 (39.4%) having 65 definitive instances of OIAE. Sixteen different OIAE were identified. Ipilimumab monotherapy and ipilimumab/nivolumab combination therapy were most commonly associated. Anterior uveitis was the most common OIAE (18/65, 27.7%). Thirty patients (69.8%) were managed with observation or topical steroid therapy. Only 4 patients required further therapies for OIAE, with one patient not attaining resolution.

CONCLUSIONS AND RELEVANCE: While a broad range of OIAE was identified, most were not vision-threatening and did not require discontinuation of the associated therapy.

Для цитирования: Philip Andrew M, Anesi Stephen D, Foster C Stephen, Chang Peter. Ocular Inflammatory Complications of Treatment for Metastatic Melanoma.. Ocular immunology and inflammation. 2022. DOI: 10.1080/09273948.2022.2098147.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.